AnxA6 downregulation in HCC is associated with the downregulated SUMOylation level of AnxA6, and the SUMO1 modification of AnxA6 at the residue K579 stabilizes AnxA6 protein itself to counteract ubiquitin-mediated degradation. The gene discussed is ANXA6; the disease is hepatocellular carcinoma.